Kevin Selby

BACKGROUND: The fecal immunochemical test (FIT) is widely used for colorectal cancer (CRC) screening, but there are no published randomized trials or well-designed observational studies on its effectiveness and whether effectiveness varies by cancer location or demographic groups…

In 2019, a BMJ Rapid Recommendation panel judged that for adults with a predicted 15-year risk of CRC below 3%, the benefits of colorectal cancer (CRC) screening would not outweigh the burdens and potential harms. The panel recommended against CRC screening for these individuals…